First, to assess whether c-MYC directly mediates MARK4 transcription, MARK4 expression was detected in c-MYC-knockdown breast cancer cells, where its expression was significantly downregulated in MDA-MB-231 and BT549 cells (Supplementary Fig. 5a, b). The gene discussed is MARK4; the disease is breast cancer.